Surface functionalized gold nanoparticles for drug delivery

Journal of Biomedical Nanotechnology

Volumn 9, Issue 8, 2013, Pages 1362-1369

  Cheng, Jinping ^a,b   Gu, Yan Juan ^c   Cheng, Shuk Han ^b   Wong, Wing Tak ^c,d  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation)   (China)

Author keywords

Biocompatibility; Doxorubicin; Drug delivery; Gold nanoparticles; Multidrug resistance

Indexed keywords

ACCUMULATION PROFILES; CONFOCAL MICROSCOPY IMAGING; DIFFERENTIAL INTERFERENCE CONTRAST IMAGING; DOXORUBICIN; DRUG DELIVERY VEHICLES; FUNCTIONALIZED GOLD NANOPARTICLES; GOLD NANOPARTICLES; MULTIDRUG RESISTANCE;

BIOCOMPATIBILITY; CELL CULTURE; CELLS; CHEMOTHERAPY; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY; GOLD; NANOCONJUGATES; ORGANIC ACIDS; POLYETHYLENE GLYCOLS;

METAL NANOPARTICLES;

DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; FOLIC ACID; GOLD NANOPARTICLE; MACROGOL; NANOCONJUGATE;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CANCER CHEMOTHERAPY; CELL STRAIN HEPG2; CELLS; CONFOCAL MICROSCOPY; CYTOPLASM; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RETENTION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIDRUG RESISTANCE; NEWBORN; PARTICLE SIZE; TARGET CELL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; GOLD; HEP G2 CELLS; HUMANS; MATERIALS TESTING; METAL NANOPARTICLES; MODELS, BIOLOGICAL; NANOCONJUGATES; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES;

EID: 84880901791     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1536     Document Type: Article

References (27)

1. R. A. Kudgus, R. Bhattacharya, and P. Mukherjee, Cancer nanotechnology: Emerging role of gold nanoconjugates. Anticancer Agents Med. Chem. 11, 965 (2011).
2. A. M. Yu, Z. J. Liang, J. H. Cho, and F. Caruso, Nanostructured electrochemical sensor based on dense gold nanoparticle films. Nano Lett. 3, 1203 (2003).
3. K. Cho, X. Wang, S. Nie, Z. G. Chen, and D. M. Shin, Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14, 1310 (2008).
4. B. Haley and E. Frenkel, Nanoparticles for drug delivery in cancer treatment. Urol. Oncol. 26, 57 (2008).
5. Y. J. Gu, J. P. Cheng, C. C. Lin, Y. W. Lam, S. H. Cheng, and W. T. Wong, Nuclear penetration of surface functionalized gold nanoparticles. Toxicol. Appl. Pharmacol. 237, 196 (2009).
6. S. Rana, A. Bajaj, R. Mout, and V. M. Rotello, Monolayer coated gold nanoparticles for delivery applications. Adv. Drug Deliv. Rev. 64, 200 (2012).
7. S. Lee, E. J. Cha, K. Park, S. Y. Lee, J. K. Hong, I. C. Sun, S. Y. Kim, K. Choi, I. C. Kwon, K. Kim, and C. H. Ahn, A near-infrared-fluorescence- quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew. Chem. Int. Ed. 47, 2804 (2008).
8. B. Dubertret, M. Calame, and A. J. Libchaber, Single-mismatch detection using gold-quenched fluorescent oligonucleotides. Nat. Biotechnol. 19, 365 (2001).
9. G. Han, P. Ghosh, and V. M. Rotello, Multi-functional gold nanoparticles for drug delivery. Adv. Exp. Med. Biol. 620, 48 (2007).
10. C. K. Kim, P. Ghosh, and V. M. Rotello, Multimodal drug delivery using gold nanoparticles. Nanoscale 1, 61 (2009).
11. F. Wang, Y. C. Wang, S. Dou, M. H. Xiong, T. M. Sun, and J. Wang, Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 5, 3679 (2011).
12. Y. J. Gu, J. Cheng, C. W. Man, W. T. Wong, and S. H. Cheng, Gold-doxorubicin nanoconjugates for overcoming multidrug resistance. Nanomedicine: Nanotechnology, Biology, and Medicine 8, 204 (2012).
13. K. N. Ganjoo, New developments in targeted therapy for soft tissue sarcoma. Curr. Oncol. Rep. 12, 261 (2010).
14. R. R. Patil, S. A. Guhagarkar, and P. V. Devarajan, Engineered nanocarriers of doxorubicin: A current update. Crit Rev. Ther. Drug Carrier Syst. 25, 1 (2008).
15. C. Carvalho, R. X. Santos, S. Cardoso, S. Correia, P. J. Oliveira, M. S. Santos, and P. I. Moreira, Doxorubicin: The good, the bad and the ugly effect. Curr. Med. Chem. 16, 3267 (2009).
16. M. Orditura, F. Quaglia, F. Morgillo, E. Martinelli, E. Lieto, G. De Rosa, D. Comunale, M. R. Diadema, F. Ciardiello, G. Catalano, and F. De Vita, Pegylated liposomal doxorubicin: Pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity. Oncol. Rep. 12, 549 (2004).
17. K. Chatterjee, J. Zhang, N. Honbo, and J. S. Karliner, Doxorubicin cardiomyopathy. Cardiology 115, 155 (2010).
18. N. V. Nukolova, H. S. Oberoi, S. M. Cohen, A. V. Kabanov, and T. K. Bronich, Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 32, 5417 (2011).
19. Y. J. Lu and P. S. Low, Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug. Deliv. Rev. 54, 675 (2002).
20. M. Das, D. Mishra, P. Dhak, S. Gupta, T. K. Maiti, A. Basak, and P. Pramanik, Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging. Small 5, 2883 (2009).
21. J. Y. W. Chan, A. C. Y. Chu, and K. P. Fung, Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. Life Sci. 67, 2117 (2000).
22. E. R. Gillies and J. M. J. Frechet, pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug. Chem. 16, 361 (2005).
23. J. H. Liu, L. Cao, P. J. G. Luo, S. T. Yang, F. S. Lu, H. F. Wang, M. J. Meziani, S. A. Haque, Y. F. Liu, S. Lacher, and Y. P. Sun, Fullerene-conjugated doxorubicin in cells. ACS Applied Materials & Interfaces 2, 1384 (2010).
24. J. Morojanu, Nuclear import and export pathways. J. Cell. Biochem. Suppl. 32/33, 76 (1999).
25. A. G. Tkachenko, H. Xie, Y. Liu, D. Coleman, J. Ryan, W. R. Glomm, M. K. shipton, S. Franzen, and D. L. Feldheim, Cellular trajectories of peptide-modified gold particles complexes: Comparison of nuclear localization signal and peptide transduction domains. Bioconjugate Chem. 15, 482 (2004).
26. I. Ojima, Guided molecular missiles for tumor-targeting chemotherapy-case studies using the second-generation taxoids as warheads. Acc. Chem. Res. 41, 108 (2008).
27. J. Chen, S. Che, X. Zhao, L. V. Kuznetsova, S. S. Wong, and I. Ojima, Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J. Am. Chem. Soc. 130, 16778 (2008).